Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative therapies for serious muscle diseases. Founded in 2017, Dyne has quickly established itself in the biopharmaceutical industry, particularly in the realm of gene therapy and muscle-targeted drug development. The company’s core offerings include its proprietary FORCE™ platform, which enables the creation of targeted therapies that address the underlying causes of muscle disorders. This unique approach positions Dyne Therapeutics as a leader in the market, with a commitment to transforming the lives of patients suffering from debilitating conditions. With significant advancements in its research and development pipeline, Dyne Therapeutics continues to make notable strides, solidifying its reputation as a key player in the biotechnology sector.
DitchCarbon Score
How does Dyne Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dyne Therapeutics, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dyne Therapeutics, Inc.'s reported carbon emissions
Dyne Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific climate commitments outlined in their reduction initiatives. As such, there are no reported figures for their carbon emissions, including Scope 1, 2, or 3 emissions. Without defined reduction targets or commitments to industry-standard climate initiatives, it is unclear how the company plans to address its carbon footprint or contribute to climate action. In the absence of specific data, it is essential for stakeholders to monitor Dyne Therapeutics' future disclosures regarding their environmental impact and sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dyne Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
